Meeting
2023 ASCO Gastrointestinal Cancers Symposium
What genes predict response to neoadjuvant chemoradiation in locally advanced rectal cancer? A systematic review based on gene expression profiling.
Authors
Michelle Or
Sydney West Radiation Oncology Network, Western Sydney Local Health District, Westmead, NSW, Australia, Sydney, NSW, Australia;
Michelle Or , Jessica Lin , Johnson Lam , Eric Hau , Puma Sundaresan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 200)
DOI
10.1200/JCO.2023.41.4_suppl.200
Abstract #
200
Poster Bd #
L2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The prediction of pathological complete response after total neoadjuvant therapy for locally advanced rectal cancer using versatile liquid biopsy.
First Author: Akihisa Matsuda
Poster
2022 ASCO Annual Meeting
Preoperative chemoradiotherapy with capecitabine with or without temozolomide in patients with locally advanced rectal cancer: A prospective, randomized phase 2 study stratified by MGMT (O6-methylguanine DNA methyltransferase) status: KCSG-CO17-02.
First Author: Chung Ryul Oh
Poster
2018 Gastrointestinal Cancers Symposium
Microsatellite instability as a predictive marker for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
First Author: Rebecca Maria Shulman
Poster
2017 ASCO Annual Meeting
Phase I study of trametinib with neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC).
First Author: Christina Sing-Ying Wu